The Endocannabinoid System as a Target for Ischemic Stroke Therapy
Cannabis & Cannabinoid Research · 2025
DOI: 10.1089/can.2024.0017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cannabis & Cannabinoid Research, 2025. Verfasst von Solange de Souza Stork und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit, University of South Sa…. Hauptthemen laut MEDLINE: Endocannabinoids, Ischemic Stroke, Cannabinoids, Stroke. Die Arbeit nennt 185 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Cannabinoids are increasingly being explored as a potential treatment for neurodegenerative diseases. This article aims to provide a narrative review of available data on the treatment of neurological disorders with cannabis constituents, focusing on ischemic stroke.
Methods
Selected articles are summarized to describe design, results, limitations, conclusions, and implications about this theme.
Results
The growing understanding of the endocannabinoid system and the cannabinoid receptors distribution in all human body systems and organs and particularly in brain structures importantly involved in myelination processes, suggests potential benefits for stroke symptoms and overall patient improvement. However, the variety of studied compounds, the different administration routes, dosages, and timing complicates data comparison, especially due to limited studies about these compounds, peculiarly in stroke patients. Thereat, this review to showcase disparities in findings and to summarize current advancements in cannabinoid use for potential future treatments.
Conclusion
This article offers a review of the current literature in the field and discuss a pragmatic approach to the clinical use of cannabinoids in patients with ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit, University of South Santa Catarina, Tubarão, SC, Brazil.
- Laboratory of Experimental Neurology, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil.
- Experimental Neuroscience Laboratory (LaNex), Postgraduate Program in Health Sciences, University of South Santa Catarina, Palhoça, Brazil.
ORCID-Profile: Solange de Souza Stork, Richard Simon Machado, Rafael Mariano Bitencourt, Fabricia Petronilho
Zitieren
APA
de Souza Stork, S., Mathias, K., Dos Santos, D., Lippert, F. W., Machado, R. S., Maragno, V. D., Joaquim, L., Stork, S. S., Bitencourt, R. M., Bobinski, F., & Petronilho, F. (2025). The Endocannabinoid System as a Target for Ischemic Stroke Therapy. Cannabis & Cannabinoid Research. https://doi.org/10.1089/can.2024.0017
Vancouver
de Souza Stork S, Mathias K, Dos Santos D, Lippert FW, Machado RS, Maragno VD, et al. The Endocannabinoid System as a Target for Ischemic Stroke Therapy. Cannabis & Cannabinoid Research. 2025. doi:10.1089/can.2024.0017
BibTeX
@article{deSouzaStork2025,
author = {de Souza Stork, Solange and Mathias, Khiany and Dos Santos, David and Lippert, Fabrício Weinheimer and Machado, Richard Simon and Maragno, Victor Duílio and Joaquim, Larissa and Stork, Samara Souza and Bitencourt, Rafael Mariano and Bobinski, Franciane and Petronilho, Fabricia},
title = {The Endocannabinoid System as a Target for Ischemic Stroke Therapy},
journal = {Cannabis & Cannabinoid Research},
year = {2025},
doi = {10.1089/can.2024.0017}
}
EUVIMED